Body
A team of researchers at McMaster University has developed a reliable and accurate blood test to track individual fat intake, a tool that could guide public health policy on healthy eating.
Establishing reliable guidelines has been a significant challenge for nutritional epidemiologists until now, because they have to rely on study participants faithfully recording their own consumption, creating results that are prone to human error and selective reporting, particularly when in the case of high-fat diets.
(Jena, Germany) Photopharmacology investigates the use of light to switch the effect of drugs on and off. Now, for the first time, scientific teams from Jena, Munich, and New York have succeeded in using this method to control a component of cells that was previously considered inaccessible.
Present everywhere and now selectively controllable
CORVALLIS, Ore. -- Whether for convenience, cost or comfort, many people look to online resources for fitness and exercise information -- especially when faced with fitness center and gym closures during the COVID-19 pandemic.
Unfortunately, most internet-based recommendations for physical activity don't match up with the guidelines supported by national health organizations, a recent study from Oregon State University found.
DURHAM, N.C. -- Biomedical engineers at Duke University have devised a new imaging device capable of measuring both the thickness and texture of the various layers of the retina at the back of the eye. The advance could be used to detect a biomarker of Alzheimer's disease, potentially offering a widespread early warning system for the disease.
The results appear online on May 13 in the journal Scientific Reports.
The Washington Post's depiction of autism has shifted over the years from a focus on "cause and cure" toward one of acceptance and accommodation, say the authors of a study that examined 315 articles published from 2007 to 2017.
Treatment with antivirals such as interferons may significantly improve virus clearance and reduce levels of inflammatory proteins in COVID-19 patients, according to a new study in Frontiers in Immunology.
DALLAS, May 15, 2020 -- Low-income adults in the United States were significantly less likely to be screened for cardiovascular disease (CVD) or receive counseling for CVD risk factors, according to research presented today at the American Heart Association's Quality of Care & Outcomes Research Scientific Sessions 2020. The virtual conference, to be held May 15-16, is a premier global exchange of the latest advances in quality of care and outcomes research in cardiovascular disease and stroke for researchers, health care professionals and policymakers.
The world is currently facing a global pandemic without precedence. Looking at how leading research organizations and scientists across all disciplines are actively redeploying efforts to help identify and implement solution is encouraging and exciting to observe, the authors of the commentary say. "This does not mean, however, that we may lose sight of the challenges we are already facing and which are responsible for threatening the lives and quality of lives of billions of people.
The delayed response of U.S. policymakers to the COVID-19 pandemic comes as no surprise to University of Wyoming Professor Jason Shogren and several of his economist colleagues at other institutions.
That's because the threat of a catastrophic pandemic in 2014 -- the West African Ebola outbreak -- did little to change the perception of U.S. citizens regarding the importance of preparing for future outbreaks, according to research conducted by Shogren and his colleagues.
Hennigsdorf/Berlin, Germany, May 14, 2020 - Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients. DPP3 is a proprietary biomarker of 4TEEN4 for hemodynamic instability and cardiac depression.
A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19). The eight patients also had a condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which is characterized by overactivation of the immune system and organ failure. One patient, who did not require mechanical ventilation, improved rapidly after starting treatment with the drug and was discharged from the hospital 9 days later.
TAMPA, Fla. -- Prostate cancer is the most common cancer in men. One in nine men will be diagnosed during their lifetime. While most men will not die from prostate cancer, there is a small subset of patients whose disease is so aggressive at the time of diagnosis that surgery and radiation are not able to control their cancer. Researchers in the Center of Excellence for Evolutionary Therapy at Moffitt Cancer Center want to better understand what is happening in the tumor microenvironment to drive prostate cancer to become aggressive and grow rapidly.
A new report authored by Pool Re and Cranfield University's Andrew Silke, Professor of Terrorism, Risk and Resilience, reveals how the COVID-19 pandemic is already having a significant impact on terrorism around the world.
The report, 'COVID-19 and terrorism: assessing the short-and long-term impact' reveals:
There is a mixed picture on the level of attacks in the short-term - lockdown measures will tend to inhibit attacks but terrorist propaganda calling for attacks (while authorities are distracted, etc.) will incite some incidents.
Researchers from Russia and Italy have proposed a compact sensor system that can implement the functionality of the electronic nose and developed a reproducible technology for its manufacture. This device is designed as flexible electronics that can analyze exhaled air, as well as identify pathologies of the respiratory tract and organs.
INDIANANAPOLIS--As COVID-19 continues its sweep around the globe, dialysis units have continued to be hotspots for the virus' spread. Researchers at Indiana University School of Medicine hope to combat that threat, through a novel study published May 14, 2020 in JAMA. The study, conducted by members of the Pediatric Nephrology Dialysis Unit at Riley Hospital for Children at IU Health, used antibody testing on patients, doctors, nurses and staff within the unit to track symptomatic and asymptomatic spread in a confined space, such as a dialysis unit.